Decreased type II/type I TGF-β receptor ratio in cells derived from human atherosclerotic lesions: Conversion from an antiproliferative to profibrotic response to TGF-β1

Journal of Clinical Investigation

Volumn 96, Issue 6, 1995, Pages 2667-2675

  McCaffrey, Timothy A ^a,b   Consigli, Seth ^a   Du, Baoheng ^a   Falcone, Domenick J ^b   Sanborn, Timothy A ^a   Spokojny, Artur M ^a   Bush Jr , Harry L ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Atherosclerosis; Cell proliferation; Extracellular matrix; Restenosis; Transforming growth factor 1 receptors

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ANGIOPLASTY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; COLLAGEN SYNTHESIS; CROSS LINKING; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MITRAL VALVE STENOSIS; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ACTINS; ARTERIOSCLEROSIS; BASE SEQUENCE; BETA-GALACTOSIDASE; CELL DIVISION; COMPARATIVE STUDY; CORONARY DISEASE; CORONARY VESSELS; DNA PRIMERS; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION; HUMAN; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMERASE CHAIN REACTION; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RECOMBINANT PROTEINS; REFERENCE VALUES; RNA, MESSENGER; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0028859484     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118333     Document Type: Article

References (52)

1. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (Lond.). 362:801-809.
2. O'Brien, E. R., C. E. Alpers, D. K. Stewart, M. Ferguson, N. Tran, D. Gordon, E. P. Benditt, T. Hinohara, J. B. Simpson, and S. M. Schwartz. 1993. Proliferation in primary and restenotic coronary atherectomy tissue: implications for antiproliferative therapy. Circ. Res. 73:223-231.
3. MacLeod, D. C., B. H. Strauss, M. De Jong, J. Escaned, R.-J. van Suylen, P. W. Serruys, and P. J. De Feyter. 1994. Proliferation and extracellular matrix synthesis of smooth muscle cells cultured from human coronary atherosclerotic and restenotic lesions. J. Am. Coll. Cardiol. 23:59-65.
4. McCaffrey, T. A., K. B. Pomerantz, T. A. Sanborn, A. M. Spokojny, B. Du, M.-H. Park, J. E. Folk, A. Lamberg, K. I. Kivirikko, D. F. Falcone, et al. 1995. Specific inhibition of elF-5A and collagen hydroxylation by a single agent. Antiproliferative and fibrosuppressive effects on smooth muscle cells from human coronary arteries. J. Clin. Invest. 95:446-455.
5. Mustoe, T. A., G. F. Pierce, A. Thomason, P. Gramates, M. Sporn, an T. F. Deuel. 1987. Accelerated healing of incisional wounds in rats induced by transforming growth factor-β. Science (Wash. DC). 237:1333-1336.
6. Raghow, R. 1991. Role of transforming growth factor-β in repair and fibrosis. Chest. 99:61s-65s.
7. Border, W. A., and N. A. Noble. 1994. Transforming growth factor-β in tissue fibrosis. N. Engl. J. Med. 331:1286-1292.
8. Nikol, S., J. M. Isner, J. G. Pickering, M. Kearney, G. Leclerc, and L. Weir. 1992. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions. J. Clin. Invest. 90:1582-1592.
9. Majesky, M. W., V. Lindner, D. R. Twardzik, S. M. Schwartz, and M. A. Reidy. 1991. Production of transforming growth factor beta 1 during repair of arterial injury. J. Clin. Invest. 88:904-910.
10. Ross, R., J. Masuda, E. W. Raines, A. M. Gown, S. Katsuda, M. Sasahara, L. T. Malden, H. Masuko, and H. Sato. 1990. Localization of PDGF-B protein in macrophages in all stages of atherogenesis. Science (Wash. DC). 248:1009-1012.
11. Sarzani, R., P. Brecher, and A. V. Chobanian. 1989. Growth factor expression in aorta of normotensive and hypertensive rats. J. Clin. Invest. 83:1404-1408.
12. Assoian, R. K., and M. B. Sporn. 1986. Type β transforming growth factor in human platelets. Release during platelet degranulation and action on vascular smooth muscle cells. J. Cell Biol. 102:1217-1223.
13. Madri, J. A., L. Bell, and J. R. Merwin. 1992. Modulation of vascular cell behavior by transforming growth factors β. Mol. Reprod. Dev. 32:121-126.
14. Nabel, E. G., L. Shum, V. J. Pompili, Z.-Y. Yang, H. San, H. B. Shu, S. Liptay, L. Gold, D. Gordon, R. Derynck, and G. J. Nabel. 1993. Direct transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia. Proc. Natl. Acad. Sci. USA. 90:10759-10763.
15. Wolf, Y. G., L. M. Rasmussen, and E. Ruoslahti. 1994. Antibodies against transforming growth factor-β1 suppress intimai hyperplasia in a rat model. J. Clin. Invest. 93:1172-1178.
16. Dartsch, P. C., R. Voisard, G. Bauridel, B. Hfling, and E. Betz. 1990. Growth characteristics and cytoskeletal organization of cultured smooth muscle cells from human primary stenosing and restenosing lesions. Arteriosclerosis. 10:62-75.
17. Chan, P., M. Patel, L. Betteridge, E. Munro, M. Schachter, J. Wolfe, and P. Sever. 1993. Abnormal growth regulation of vascular smooth muscle cells by heparin in patients with restenosis. Lancet. 341:341-342.
18. Lin, H. Y., X. F. Wang, E. Ng-Eaton, R. A. Weinberg, and H. F. Lodish. 1992. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell. 68:775-785.
19. Franzen, P., P. Dijke, H. Ichijo, H. Yamashita, H. Schulz, C.-H. Heldin, and K. Miyazono. 1993. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell. 75:681-692.
20. Derynck, R., J. A. Jarrett, E. Y. Chen, D. H. Eaton, J. R. Bell, R. K. Assoian, A. B. Roberts, M. B. Sporn, and D. V. Goeddel. 1985. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature (Lond.). 316:701-705.
21. Bjorkerud, S. 1991. Effects of transforming growth factor-β1 on human arterial smooth muscle cells in vitro. Arteriosclerosis. 11:892-902.
22. Reddy, K. B., and P. H. Howe. 1993. Transforming growth factor β1-mediated inhibition of smooth muscle cell proliferation is associated with a late G1 cell cycle arrest. J. Cell. Physiol. 156:48-55.
23. McCaffrey, T. A., and D. J. Falcone. 1993. Evidence for an age-related dysfunction in the antiproliferative response to transforming growth factor-β in vascular smooth muscle cells. Mol. Biol. Cell. 4:315-322.
24. Janat, M. F., and G. Liau. 1992. Transforming growth factor-β1 is a powerful modulator of platelet-derived growth factor action in vascular smooth muscle cells. J. Cell. Physiol. 150:232-242.
25. Kirschenlohr, H. L., J. C. Metcalfe, P. L. Weissberg, and D. J. Grainger. 1993. Adult human aortic smooth muscle cells in culture produce active TGF-β. Am. J. Physiol. Cell Physiol. 265:C571-C576.
26. Derynck, R., L. Rhee, E. Y. Chen, and A. Van Tilburg. 1987. Intron-exon structure of the human transforming growth factor-beta precursor gene. Nucleic Acids Res. 15:3188-3189.
27. Chen, R. H., R. Ebner, and R. Derynck. 1993. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science (Wash. DC). 260:1335-1338.
28. McCaffrey, T. A., D. J. Falcone, and B. Du. 1992. Transforming growth factor-β is a heparin-binding protein: identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-β1. J. Cell. Physiol. 152:430-440.
29. 2-macroglobulin inactive complex. J. Cell Biol. 109:441-448.
30. McCaffrey, T. A., D. J. Falcone, W. Borth, B. Du, S. Consigli, and D. L. Vicente. 1994. Protection of transforming growth factor-β1 activity by heparin and fucoidan. J. Cell. Physiol. 159:51-59.
31. Grainger, D. J., C. M. Witchell, J. V. Watson, J. C. Metcalfe, and P. L. Weissberg. 1993. Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor β-like activity from serum. Cardiovasc. Res. 27:2238-2247.
32. Laiho, M., O. Saksela, and J. Keski-Oja. 1987. Transforming growth factor-β induction of type-1 plasminogen activator inhibitor. J. Biol. Chem. 262:17467-17474.
33. Overall, C. M., J. L. Wrana, and J. Sodek. 1989. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J. Biol. Chem. 264:1860-1869.
34. Sato, Y., R. Tsuboi, H. Moses, and D. B. Rifkin. 1990. Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J. Cell Biol. 111:757-763.
35. Falcone, D. J., T. A. McCaffrey, A. Haimovitz-Friedman, and M. Garcia. 1993. Transforming growth factor-β1 stimulates macrophage urokinase expression and release of matrix bound basic fibroblast growth factor. J. Cell. Physiol. 155:595-605.
36. Edwards, D. R., G. Murphy, J. J. Reynolds, S. E. Whitlam, A. J. P. Docherty, and P. Angel. 1987. Transforming growth factor-β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO (Eur. Mol. Biol. Organ.) J. 6:1899-1904.
37. Rossi, P., G. Karsenty, A. Roberts, N. S. Roche, M. B. Sporn, and B. Crombrugghe. 1988. A nuclear factor-1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β. Cell. 52:405-414.
38. Raghow, R., A. E. Postlethwaite, J. Keski-Oja, H. L. Moses, and A. H. Kang. 1987. Transforming growth factor-β increases steady state levels of type I procollagen and fibronectin mRNAs posttranscriptionally in cultured human dermal fibroblasts. J. Clin. Invest. 79:1285-1288.
39. Keeton, M. R., S. A. Curriden, A. J. van Zonneveld, and D. J. Loskutoff. 1991. Identification of regulatory sequences in the type I plasminogen activator gene responsive to transforming growth factor beta. J. Biol. Chem. 266:23048-23052.
40. Liau, G., and L. M. Chan. 1989. Regulation of extracellular matrix RNA levels in cultured smooth muscle cells. Relationship to cellular quiescence. J. Biol. Chem. 264:10315-10320.
41. Shi, D. L., C. Savona, E. M. Chambaz, and J. J. Feige. 1990. Stimulation of fibronectin production by TGF-β1 is independent of effects on cell proliferation: the example of bovine adrenocortical cell. J. Cell. Physiol. 145:60-68.
42. Franzén, P., H. Ichijo, and K. Miyazono. 1993. Different signals mediate transforming growth factor-β-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells. Exp. Cell Res. 207:1-7.
43. Goodman, L. V., and R. A. Majack. 1989. Vascular smooth muscle cells express distinct transforming growth factor-β receptor phenotypes as a function of cell density in culture. J. Biol. Chem. 264:5241-5244.
44. Wrana, J. L., L. Attisano, R. Wieser, F. Ventura, and J. Massague. 1994. Mechanism of activation of the TGF-β receptor. Nature (Lond.). 370:341-347.
45. Stemerman, M. B., R. Weinstein, J. W. Rowe, T. Maciag, R. Fuhro, and R. Gardner. 1982. Vascular smooth muscle cell growth kinetics in vivo in aged rats. Proc. Natl. Acad. Sci. USA. 79:3863-3866.
46. Hariri, R. J., D. R. Alonso, D. P. Hajjar, D. Coletti, and M. E. Weksler. 1986. Aging and atherosclerosis. I. Development of myointimal hyperplasia after endothelial injury. J. Exp. Med. 164:1171-1178.
47. Mulder, K. M., M. K. Ramey, N. M. Hoosein, A. E. Levine, X. H. Hinshaw, D. E. Brattain, and M. G. Brattain. 1988. Characterization of transforming growth factor-β-resistant subclones isolated from a transforming growth factor-β-sensitive human colon carcinoma cell line. Cancer Res. 48:7120-7125.
48. Missero, C., E. Filvaroff, and G. P. Dotto. 1991. Induction of transforming growth factor β1 resistance by the E1A oncogene requires binding to a specific set of cellular proteins. Proc. Natl. Acad. Sci. USA. 88:3489-3493.
49. Pietenpol, J. A., R. W. Stein, E. Moran, P. Yaciuk, R. Schlegel, R. M. Lyons, M. R. Pittelkow, K. Munger, P. M. Howley, and H. L. Moses. 1990. TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell. 61:777-785.
50. Speir, E., R. Modali, E. S. Huang, M. B. Leon, F. Shawl, T. Finkel, and S. E. Epstein. 1994. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science (Wash. DC). 265:391-394.
51. Reiss, M., V. F. Vellucci, and Z. Zhou. 1993. Mutant p53 tumor suppressor gene causes resistance to transforming growth factor β1 in murine keratinocytes. Cancer Res. 53:899-904.
52. Markowitz, S., J. Wang, L. Myeroff, R. Parsons, L. Z. Sun, J. Lutterbaugh, R. S. Fan, E. Zborowska, K. W. Kinzler, B. Vogelstein, et al. 1995. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Wash. DC). 268:1336-1338.